ICT Compliance is a tech company specializing in authentication solutions.
Willog specializes in providing a customizable data logging and management system that enables comprehensive monitoring of logistics from production to consumer delivery. The company focuses on capturing critical environmental parameters, such as temperature, humidity, shock, and light, during transit. By offering cloud-based software as a service (SaaS), Willog facilitates analysis and oversight of the logistics process, allowing businesses to identify issues and improve communication regarding transportation progress. This approach transforms traditional opaque logistics systems into transparent ones, enhancing the efficiency and reliability of supply chain operations.
Happy Moonday Inc. is a South Korean company established in 2017 that specializes in the manufacture and sale of organic sanitary products. The company offers a range of female healthcare items, including organic cotton sanitary napkins, tampons, menstrual cups, and underwear, as well as feminine wash and heating patches. Additionally, Happy Moonday provides menstrual cycle tracking applications to assist women in managing their health and alleviating discomfort during their menstrual cycles. By focusing on organic materials, the company aims to promote healthier choices for women.
A mathematical problem solving application for middle and high school students.
S-Alpha Therapeutics Inc., a digital therapeutics company, researches and develops health applications and platform technologies that enable digital devices to treat different diseases. Its products include SAT-001, an ophthalmology related application for eye disease treatment; SAT-002, neurology application for treatment of nervous system disease; SAT-003, oncology application for recovery and treatment of cancer patients; and SAT-008, a public crisis application for overcoming social problems. Additionally, it also develops therapeutic devices. The company was founded in 2019 and is based in Seoul, South Korea.
Wavebridge is developing solutions with the goal of providing an integrated AI platform for domestic financial institutions. Services provided include financial data analysis module, financial product valuation module, risk analysis module and AI transaction solutions. Wavebridge is creating an excellent institutional network based on core competencies such as an experienced workforce suitable for building digital finance and certified technological strength by providing global solutions. Vision: “AI Automatic Trading, Integrated Asset Management Platform"
Reebonz Korea., Ltd engages in the import, export, wholesale, and retail of luxury products for men and women. The company offers bags/handbags, wallets, watch/accessories, shoes, clothing, cosmetics, and fashion accessories. It also offers products online. The company is based in Seoul, South Korea.
PeopleBio, Inc. is a biotech company focused on developing diagnostic tools for protein misfolding diseases. The company utilizes its Multimer Detection System technology, which employs capturing antibodies and epitope-overlapping detection antibodies to identify oligomers or multimers derived from monomers in such diseases. Founded in 2002 and headquartered in Seongnam, South Korea, PeopleBio has established strategic collaborations with various organizations, including Seoul National University Bundang Hospital, Etablissement Français du Sang, and Eisai Co., Ltd. These partnerships enhance its research and development efforts in the field of diagnostics.
GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.
Gencurix Inc. develops molecular diagnostic products in South Korea. Its products include GenesWell BCT, a prognosis diagnostic kit for breast cancer; GenesWell ddEGFR Mutation Test, a prognostic test for lung cancer; GenesWell CDx EGFR Mutation Test for companion diagnostics in lung cancer; and GenesWell ddEGFR Mutation Test to detect mutation site in non-small cell lung cancer samples. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Biobab AiBIO is a biotechnology company that develops drugs utilize artificial intelligence.
OliX Pharmaceuticals is a clinical stage biotechnology company based in Suwon, South Korea, specializing in the development of RNA interference (RNAi) therapeutics aimed at treating various dermal, ophthalmic, and pulmonary diseases. The company's diverse product pipeline includes treatments such as OLX101 for skin scars, OLX102 for skin whitening, OLX103 for atopic dermatitis, OLX104 for hair loss, OLX105 for anti-wrinkle applications, and OLX106 for diabetic foot ulcers. Additionally, it is developing therapies for age-related macular degeneration, retinitis pigmentosa, lung fibrosis, asthma, influenza, neuropathic pain, liver fibrosis, and cancer immunotherapy. OliX Pharmaceuticals has also formed a collaboration with Théa to advance SiRNA therapeutics specifically for ophthalmic conditions. Established in 2010, the company leverages its proprietary RNAi technology to regulate the expression of genes associated with diseases.
Trenbe Inc. sells apparel, bags, shoes, and accessories online for men and women. The company was incorporated in 2016 and is based in Seoul, South Korea.
5minlab (5민랩) develops mobile and Flash games. Its products include Project Jump Goox, which is a fairy-tale based game. 5minlab was established on Septemeber 23, 2013. It is based in Seoul, Korea.
Laundrygo is a on-demand laundry service.
Kukka, Inc. is a flower delivery service based in Seoul, South Korea, established in 2014. The company aims to promote the Finnish culture of enjoying flowers in everyday life within Korea. Kukka offers a variety of services, including flower subscriptions, bouquet deliveries, same-day delivery, and custom flower designs tailored for both individual and corporate clients. Its product range encompasses corporate event support flowers, promotional flower boxes, customer care flowers, and floral decorations. Additionally, Kukka provides flower art classes and accessories, making it easier for customers to incorporate fresh flowers into their spaces and events.
Provider of ride-hailing service platform intended to come up with scheduled car reservation service. The company's platform provides reservations of cars through calling as well as a selection of a variety of vehicles with simplified payment and discounts through its mobile application, enabling customers to enjoy a reservation-based travel experience.
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
Sparkplus is a coworking space operator based in Seoul, South Korea, founded in 2016. The company specializes in designing and managing real estate contracts, as well as overseeing interior design, construction, and furniture arrangements for office environments. By providing flexible workspace solutions, Sparkplus caters to the needs of modern businesses seeking adaptable office settings.
FamePick Inc. is a subscription-based internet platform founded in 2016 and located in Sunnyvale, California. It serves the advertising and marketing industry by providing a data-driven endorsement platform that enables marketers to find, secure, and launch celebrity-driven marketing campaigns on social media. The platform aims to create authentic celebrity experiences, allowing brands to enhance their marketing efforts through the influence of well-known personalities.
Raonsecure Co., Ltd. is an ICT security software company based in Seoul, South Korea, specializing in security solutions for financial institutions, government entities, and enterprises. Founded in 1998 and originally named Lumensoft Ltd., the company changed its name in 2012. Raonsecure primarily offers TouchEn OnePass, a biometric authentication solution designed for various applications, including payments, mobile banking, and fintech services. The company is also engaged in ICT security consulting and holds multiple patents in integrated security technologies, focusing on human/device authentication and FIDO (Fast IDentity Online) protocols based on Public Key Infrastructure (PKI) technology. Through its innovative products and services, Raonsecure aims to enhance security measures in the digital landscape.
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell-mediated diseases, including Fuchs dystrophy and other serious endothelial cell diseases. The eFGF-1 technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which debilitating and cause a significant amount of preventable blindness throughout the world. Trefoil focuses on a topical eye drop formulation of TTHX1114 for the treatment of ulcerative conditions on the front surface of the cornea which leads to corneal scarring and substantial loss of vision. The company's mission is to improve human health and create new therapies using drugs developed with protein engineering. The management team at Trefoil has more than 100 years of pharmaceutical development and commercialization experience. As an early-stage development company, Trefoil has been recognized by the biopharmaceutical funding community through the CONNECT Springboard business plan program award and the Southeast Biotechnology Early Company Competition.
TiBiT Communications offers a disruptive technology that will fundamentally change the way broadband access is deployed in the Service Provider markets worldwide (Cable MSO, Telco and Wireless). They make small, low powered solutions that can be easily placed anywhere in the network to enable multi-Gigabit connectivity for low end cost effective switching equipment in a Software Defined Network.
Innopharmascreen
Series A in 2019
Innopharmascreen is a ICT based drug discovery company.
WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company’s products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Seoul, South Korea.
bHaptics is a developing a full-body and fully programmable haptic solution for Virtual Reality (VR)
Kymera Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts, established in 2015. It specializes in targeted protein degradation, developing innovative small molecule therapeutics that selectively degrade proteins associated with various diseases by utilizing the body's natural protein degradation mechanisms. The company is advancing several therapeutic programs, including the IRAK4 program aimed at treating immunology-inflammation diseases such as hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis. Additionally, it is developing the IRAKIMiD program for MYD88-mutated diffuse large B cell lymphoma and the STAT3 program for hematologic malignancies and solid tumors, as well as autoimmune diseases. Through its proprietary predictive modeling platform, Kymera Therapeutics seeks to accelerate drug discovery and address previously untreatable conditions.
Vendys Inc. is a South Korean company that provides a mobile meal voucher service aimed at enhancing employee welfare. Established in 2014, Vendys offers a digital platform that enables companies to manage dining for their employees through mobile applications. The service includes mobile food stamps, canteen meal coupons, and discount promotions, aimed at improving staff engagement and dining experiences. By partnering with local restaurants, Vendys facilitates convenient meal options for office workers, promoting a better dining culture within the workplace. The company is headquartered in Seoul and operates primarily in the staff welfare sector.
Newploy develops a platform for salary calculation, transfer, report, and payment. The company was founded in 2014 and is based in Seoul, South Korea.
Albam : A mobile based HR Solution that is available for both Managers(Admins) and Staffs in App both IOS & Android. The average HR manager spends 45 minutes a day to calculate time attendance & payroll. With Albam, time is reduced by 70% to only 15 minutes. Albam help enterprises in simplifying and automating their time attendance system to payroll solution. Our easy to use and simple Cloud based Human Resource solution helps companies in reducing the high costs that are often associated in the investment of Time Attendance system which includes the purchase of expensive fingerprint machines and training of IT Personnels. With Albam, employees can clock in and clock out directly right away from their smartphone, clock in and clock out has never been this easier with Albam.
Triple Corp. operates a cloud based travel platform. Its product triple, is an application which is designed to help the user in real time location sharing. The company was founded in 2016 and is based in Seongnam, South Korea.
WATCHA - Launched in AUG 2012, it quickly became Korea’s favorite movie review app - Its core competency lies in personalized recommendation technology - once users rate movie, WATCHA predicts how they will like movies they haven’t yet seen - Now provides the widest and most accurate movie, TV show and book reviews - Launched in Japan in 2015 WATCHA PLAY - Launched in JAN 2016 - Subscription VOD service for movie and TV series available on multiple devices including Web, iOS/Android mobile and tablet, Samsung/LG Smart TV, Google Chromecast, Android TV - Provides extremely accurate personalized content recommendation, powered by WATCHA - 75% of content consumed based on recommendations Comment by Apple, App Store Editor Team “Thanks to its large volume of reliable review data collected from users, WATCHA PLAY can recommend contents that perfectly satisfy my taste. Please don’t waste your time in choosing what to watch. Trust WATCHA PLAY and Enjoy tonight”
Kezar Life Sciences, Inc. is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing novel small molecule therapeutics for unmet medical needs in autoimmunity and cancer. The company’s lead candidate, KZR-616, is a selective immunoproteasome inhibitor currently undergoing Phase 2 clinical trials for multiple autoimmune conditions, including lupus nephritis and autoimmune hemolytic anemia, as well as Phase 1b/2 trials for systemic lupus erythematosus. In addition to KZR-616, Kezar is advancing preclinical products, including KZR-TBD, aimed at treating oncology and autoimmune disorders. Founded in 2015, Kezar Life Sciences leverages insights into protein homeostasis, particularly the interplay between protein degradation and secretion, to drive its drug discovery efforts.
Private Equity Round in 2017
Yanolja is the fastest-growing No.1 OTA, and the only ‘Unicorn’ among travel related companies in South Korea. In the online business, as a ‘Super App’, Yanolja provides all services for travel including accommodation, leisure and transportation. In the offline sector, it is one of the largest franchise operators in Southeast Asia, managing more than 10,000 rooms. It is also Asia’s best full-stack hospitality company, supplying an integrated hotel platform by effectively utilizing IoT, AI and blockchain technologies. Yanolja is now also one of the global Top 2 PMS providers. It has integrated entire hotel operations, covering from front office to back office including housekeeping and maintenance. Yanolja connects the B2B2C value chain of the travel industry with a one-stop network and integrates it into a single platform.
Blind is a community app that connects verified professionals to facilitate discussions on important workplace topics. Founded in 2013 and based in Irvine, California, with additional offices in Seoul and San Francisco, Blind allows users to communicate anonymously in private company channels and engage openly across various industries. With a global user base of over 4.1 million professionals, the platform serves as a space for sharing advice, providing feedback, and exploring relevant career information. By promoting transparency and fostering honest dialogue, Blind aims to empower users to make informed decisions and inspire positive changes in their workplaces.
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell-mediated diseases, including Fuchs dystrophy and other serious endothelial cell diseases. The eFGF-1 technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which debilitating and cause a significant amount of preventable blindness throughout the world. Trefoil focuses on a topical eye drop formulation of TTHX1114 for the treatment of ulcerative conditions on the front surface of the cornea which leads to corneal scarring and substantial loss of vision. The company's mission is to improve human health and create new therapies using drugs developed with protein engineering. The management team at Trefoil has more than 100 years of pharmaceutical development and commercialization experience. As an early-stage development company, Trefoil has been recognized by the biopharmaceutical funding community through the CONNECT Springboard business plan program award and the Southeast Biotechnology Early Company Competition.
Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, dedicated to developing therapeutic compounds that inhibit the complement system to address autoimmune and inflammatory diseases. The company's lead candidate, pegcetacoplan, is undergoing Phase III clinical trials for geographic atrophy associated with age-related macular degeneration and paroxysmal nocturnal hemoglobinuria, while also being assessed in Phase II trials for several other conditions, including cold agglutinin disease and lupus nephritis. Additionally, Apellis is developing APL-9, which is currently in Phase I clinical trials aimed at preventing immune activation related to adeno-associated virus. The company collaborates with Swedish Orphan Biovitrum AB to advance pegcetacoplan for various rare diseases. Founded in 2009, Apellis focuses on creating innovative therapies for conditions characterized by excessive activation of the complement cascade across multiple medical fields, including hematology and ophthalmology.
Dano (다노) is a Korea-based company that develops diet apps for the health and fitness sector. Dano’s Diet App is a journal-based app that enables users to stay focused and monitor their daily progress. The app offers many useful tools to help users stay committed to their diet programs. Dano also released Diet Cover, a lock-screen photo app that enables users to have a photo of their role model, in order to remind themselves about their diet during the course of the day. This app enables users to eat healthily and be mindful of their diet at any given moment. Dano was established in July 2013.
Clearside Biomedical, Inc., a biopharmaceutical company, develops and delivers treatment that restore and preserve vision for people with serious eye diseases. Its preclinical products include CLS-AX, an axitinib for suprachoroidal injection. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
12cm operates echoss, a cloud O2O service platform that provides offline to mobile connection services. The company also offers echoss stamp products. 12cm’s platform also includes a service mobile plugin, commerce service, and coupon service components. In addition, its echoss platform is applied and extended to O2O service, including membership, promotion, mobile certification, commerce, and utility. It is based in Bundangdong, Kyonggi-do.
Remember is the number one business card management application in Korea that secretary inputs directly when you take a business card.
Kezar Life Sciences, Inc. is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing novel small molecule therapeutics for unmet medical needs in autoimmunity and cancer. The company’s lead candidate, KZR-616, is a selective immunoproteasome inhibitor currently undergoing Phase 2 clinical trials for multiple autoimmune conditions, including lupus nephritis and autoimmune hemolytic anemia, as well as Phase 1b/2 trials for systemic lupus erythematosus. In addition to KZR-616, Kezar is advancing preclinical products, including KZR-TBD, aimed at treating oncology and autoimmune disorders. Founded in 2015, Kezar Life Sciences leverages insights into protein homeostasis, particularly the interplay between protein degradation and secretion, to drive its drug discovery efforts.
Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, dedicated to developing therapeutic compounds that inhibit the complement system to address autoimmune and inflammatory diseases. The company's lead candidate, pegcetacoplan, is undergoing Phase III clinical trials for geographic atrophy associated with age-related macular degeneration and paroxysmal nocturnal hemoglobinuria, while also being assessed in Phase II trials for several other conditions, including cold agglutinin disease and lupus nephritis. Additionally, Apellis is developing APL-9, which is currently in Phase I clinical trials aimed at preventing immune activation related to adeno-associated virus. The company collaborates with Swedish Orphan Biovitrum AB to advance pegcetacoplan for various rare diseases. Founded in 2009, Apellis focuses on creating innovative therapies for conditions characterized by excessive activation of the complement cascade across multiple medical fields, including hematology and ophthalmology.
Aileron Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing a novel class of drugs known as stabilized cell-permeating alpha-helical peptides, particularly in the field of oncology. The company’s lead drug candidate, ALRN-6924, is currently undergoing multiple clinical trials, including Phase 2a studies for advanced solid tumors and peripheral T-cell lymphoma, as well as Phase 1 trials for acute myeloid leukemia and advanced myelodysplastic syndrome. Aileron is also working on a next-generation wild type p53 reactivator. Collaborations with notable institutions, such as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Pfizer, further enhance its research efforts, particularly in evaluating ALRN-6924 in combination therapies. Aileron Therapeutics was founded in 2001, originally named Renegade Therapeutics, and is headquartered in Watertown, Massachusetts.
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas, dedicated to discovering and developing biologic therapeutics for cancer treatment. The company utilizes a proprietary platform known as engineered toxin bodies to create targeted therapies. Its lead candidate, MT-3724, is currently undergoing Phase II clinical trials for relapsed and refractory diffuse large B-cell lymphoma and non-Hodgkin’s lymphoma. In addition, the company is developing other candidates, including MT-4019, which targets CD38, and has collaborations with Takeda Pharmaceutical Company and Vertex Pharmaceuticals. These partnerships aim to enhance treatment options for conditions like multiple myeloma and improve outcomes in hematopoietic stem cell transplants. Molecular Templates continues to expand its pipeline with additional compounds targeting various cancers.
Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.
Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.
Shanghai Fangtek Electronics Co., Ltd. is a company based in Shanghai, China, specializing in the design, development, and marketing of analog and mixed-signal power management integrated circuits. Founded in 2003, it offers a range of products including audio power amplifiers, LED drivers, SIM card controllers, analog switches, reset integrated circuits, charger protection devices, and voltage regulators. These products cater to various applications in the communication, computing, and consumer electronics sectors, including mobile phones, MP3/4 players, GPS devices, and mini sound boxes. Fangtek Electronics focuses on providing high-performance and cost-effective solutions, leveraging its expertise in power device technology and mixed-signal design to serve the needs of audio, lighting, and voltage regulation markets. The company also operates an office in Shenzhen, China, enhancing its reach and service capabilities.